title: Bullous Pemphigoid Associated With Linagliptin Treatment.
authors.affiliation: Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon2Faculty of Medicine, Saint Joseph University, Beirut Lebanon.
authors.forename: Roger
authors.initials: R
authors.lastname: Haber
authors.affiliation: Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon2Faculty of Medicine, Saint Joseph University, Beirut Lebanon.
authors.forename: Alice Mouna
authors.initials: AM
authors.lastname: Fayad
authors.affiliation: Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon2Faculty of Medicine, Saint Joseph University, Beirut Lebanon.
authors.forename: Farid
authors.initials: F
authors.lastname: Stephan
authors.affiliation: Department of Dermatology, Sacre Coeur Hospital, Beirut, Lebanon.
authors.forename: Grace
authors.initials: G
authors.lastname: Obeid
authors.affiliation: Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon2Faculty of Medicine, Saint Joseph University, Beirut Lebanon.
authors.forename: Roland
authors.initials: R
authors.lastname: Tomb
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069476:Linagliptin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000473:pathology
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D000069476:Linagliptin